Acrivon Therapeutics shares owned by DAFNA Capital Management
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by DAFNA Capital Management
from 13F filings
Historical chart of DAFNA Capital Management investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Acrivon Therapeutics by DAFNA Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $646k | 131k | 4.92 |
2023-09-30 | $735k | 77k | 9.56 |
2023-06-30 | $996k | 77k | 12.96 |
2023-03-31 | $649k | 51k | 12.69 |
2022-12-31 | $180k | 16k | 11.52 |